NCS TESTING TECHNOLOGY CO., LTD. Financials NCS Testing Technology Co., Ltd.
Equities
300797
CNE100003QQ1
Industrial Machinery & Equipment
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.66 CNY | +2.01% |
|
-1.30% | -16.91% |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Capitalization 1 | 5,294 | 3,981 | 4,353 | 3,856 | 4,916 |
| Enterprise Value (EV) 1 | 4,875 | 3,541 | 4,100 | 3,589 | 4,754 |
| P/E ratio | 60.6 x | 51.6 x | 51.7 x | 33 x | 38.4 x |
| Yield | 0.13% | 0.2% | 0.58% | 0.89% | 0.78% |
| Capitalization / Revenue | 9.69 x | 6.8 x | 6.2 x | 4.73 x | 5.18 x |
| EV / Revenue | 8.92 x | 6.05 x | 5.84 x | 4.4 x | 5.01 x |
| EV / EBITDA | 73.5 x | 51.3 x | 42.2 x | 39.5 x | 37.2 x |
| EV / FCF | -348 x | 1,334 x | -92.2 x | -128 x | -73.2 x |
| FCF Yield | -0.29% | 0.07% | -1.09% | -0.78% | -1.37% |
| Price to Book | 7.39 x | 5.05 x | 5.13 x | 4.08 x | 4.67 x |
| Nbr of stocks (in thousands) | 372,300 | 372,300 | 372,300 | 382,515 | 383,175 |
| Reference price 2 | 14.22 | 10.69 | 11.69 | 10.08 | 12.83 |
| Announcement Date | 4/20/20 | 3/25/21 | 4/21/22 | 4/20/23 | 4/18/24 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 505.6 | 546.4 | 585.5 | 701.6 | 815.4 | 949.5 |
| EBITDA 1 | 66.95 | 66.37 | 68.96 | 97.19 | 90.81 | 127.9 |
| EBIT 1 | 53.78 | 51.61 | 52.14 | 72.82 | 62.37 | 83.78 |
| Operating Margin | 10.64% | 9.45% | 8.91% | 10.38% | 7.65% | 8.82% |
| Earnings before Tax (EBT) 1 | 71.94 | 78.05 | 86.73 | 90.85 | 95.14 | 104.1 |
| Net income 1 | 64.23 | 69.14 | 77.22 | 84.19 | 113.8 | 125.7 |
| Net margin | 12.7% | 12.65% | 13.19% | 12% | 13.96% | 13.24% |
| EPS 2 | 0.2333 | 0.2346 | 0.2074 | 0.2261 | 0.3051 | 0.3339 |
| Free Cash Flow 1 | -26.13 | -14.02 | 2.655 | -44.48 | -28 | -64.96 |
| FCF margin | -5.17% | -2.57% | 0.45% | -6.34% | -3.43% | -6.84% |
| FCF Conversion (EBITDA) | - | - | 3.85% | - | - | - |
| FCF Conversion (Net income) | - | - | 3.44% | - | - | - |
| Dividend per Share | - | 0.0187 | 0.0213 | 0.0680 | 0.0893 | 0.1000 |
| Announcement Date | 10/13/19 | 4/20/20 | 3/25/21 | 4/21/22 | 4/20/23 | 4/18/24 |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 155 | 419 | 440 | 254 | 266 | 162 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | -26.1 | -14 | 2.66 | -44.5 | -28 | -65 |
| ROE (net income / shareholders' equity) | 17.3% | 12.4% | 10.3% | 10.3% | 10.3% | 9.86% |
| ROA (Net income/ Total Assets) | 5.34% | 3.86% | 3.1% | 3.67% | 2.56% | 2.95% |
| Assets 1 | 1,202 | 1,789 | 2,489 | 2,296 | 4,443 | 4,257 |
| Book Value Per Share 2 | 1.440 | 1.920 | 2.120 | 2.280 | 2.470 | 2.750 |
| Cash Flow per Share 2 | 0.5600 | 1.130 | 1.180 | 1.030 | 1.000 | 0.6900 |
| Capex 1 | 55.4 | 47.7 | 81.1 | 123 | 184 | 165 |
| Capex / Sales | 10.96% | 8.73% | 13.84% | 17.59% | 22.62% | 17.38% |
| Announcement Date | 10/13/19 | 4/20/20 | 3/25/21 | 4/21/22 | 4/20/23 | 4/18/24 |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -16.91% | 565M | |
| +8.05% | 33.8B | |
| +24.67% | 8.62B | |
| +14.64% | 8.22B | |
| +27.75% | 5.8B | |
| -6.30% | 4.04B | |
| +17.08% | 3.8B | |
| +12.21% | 3.71B | |
| +24.12% | 3.69B | |
| -6.79% | 2.81B |
- Stock Market
- Equities
- 300797 Stock
- Financials NCS Testing Technology Co., Ltd.
